

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.07162558 |
| 2 | negative regulation of cell killing (GO:0031342) | 7.07162558 |
| 3 | negative T cell selection (GO:0043383) | 4.57162702 |
| 4 | positive thymic T cell selection (GO:0045059) | 4.50936190 |
| 5 | positive T cell selection (GO:0043368) | 4.42609369 |
| 6 | negative thymic T cell selection (GO:0045060) | 4.36077041 |
| 7 | thymic T cell selection (GO:0045061) | 4.15198146 |
| 8 | interferon-gamma production (GO:0032609) | 4.05990043 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.02173420 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.98795289 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95018510 |
| 12 | T cell selection (GO:0045058) | 3.93096903 |
| 13 | regulation of T cell tolerance induction (GO:0002664) | 3.67937075 |
| 14 | activated T cell proliferation (GO:0050798) | 3.38564639 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.38425252 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.38425252 |
| 17 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.37689708 |
| 18 | T cell migration (GO:0072678) | 3.32032919 |
| 19 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.26386411 |
| 20 | T cell receptor signaling pathway (GO:0050852) | 3.25081075 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22901967 |
| 22 | response to muramyl dipeptide (GO:0032495) | 3.21662450 |
| 23 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13185938 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.09373757 |
| 25 | negative regulation of type 2 immune response (GO:0002829) | 3.05088434 |
| 26 | regulation of regulatory T cell differentiation (GO:0045589) | 3.03256205 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.01997465 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.01997465 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.01997465 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.01997465 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 3.01997465 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.01997465 |
| 33 | response to interleukin-15 (GO:0070672) | 3.00727030 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.97114231 |
| 35 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.95853220 |
| 36 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.95375973 |
| 37 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.94922217 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94875836 |
| 39 | leukocyte aggregation (GO:0070486) | 2.92086575 |
| 40 | T cell costimulation (GO:0031295) | 2.89215200 |
| 41 | heterotypic cell-cell adhesion (GO:0034113) | 2.88427694 |
| 42 | regulation of B cell differentiation (GO:0045577) | 2.87522045 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 2.87189169 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86905516 |
| 45 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86150950 |
| 46 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86150950 |
| 47 | detection of other organism (GO:0098543) | 2.86123364 |
| 48 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.86090403 |
| 49 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85854231 |
| 50 | lymphocyte costimulation (GO:0031294) | 2.84024563 |
| 51 | detection of bacterium (GO:0016045) | 2.82787802 |
| 52 | negative regulation of phagocytosis (GO:0050765) | 2.79513132 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 2.79088214 |
| 54 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.77616938 |
| 55 | leukocyte cell-cell adhesion (GO:0007159) | 2.74685354 |
| 56 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.74218804 |
| 57 | positive regulation of granulocyte differentiation (GO:0030854) | 2.73911229 |
| 58 | cellular response to interleukin-15 (GO:0071350) | 2.72045050 |
| 59 | T cell homeostasis (GO:0043029) | 2.71254265 |
| 60 | tolerance induction (GO:0002507) | 2.68647630 |
| 61 | T cell differentiation (GO:0030217) | 2.68156091 |
| 62 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.67444462 |
| 63 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.66695174 |
| 64 | cell adhesion mediated by integrin (GO:0033627) | 2.66458663 |
| 65 | positive regulation of tolerance induction (GO:0002645) | 2.66296010 |
| 66 | regulation of isotype switching (GO:0045191) | 2.65541366 |
| 67 | regulation of cell killing (GO:0031341) | 2.65510154 |
| 68 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.65048694 |
| 69 | regulation of tolerance induction (GO:0002643) | 2.64880845 |
| 70 | hepatocyte apoptotic process (GO:0097284) | 2.63279861 |
| 71 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.63097456 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.59800601 |
| 73 | substrate-dependent cell migration (GO:0006929) | 2.58952877 |
| 74 | regulation of interleukin-4 production (GO:0032673) | 2.57385748 |
| 75 | positive regulation of mast cell activation (GO:0033005) | 2.56916779 |
| 76 | mast cell activation (GO:0045576) | 2.56899653 |
| 77 | regulation of alpha-beta T cell activation (GO:0046634) | 2.56807623 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.53180245 |
| 79 | positive regulation of cell killing (GO:0031343) | 2.50542784 |
| 80 | germ cell migration (GO:0008354) | 2.49253846 |
| 81 | cellular response to type I interferon (GO:0071357) | 2.47879645 |
| 82 | type I interferon signaling pathway (GO:0060337) | 2.47879645 |
| 83 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.47424580 |
| 84 | lymphocyte migration (GO:0072676) | 2.46680751 |
| 85 | dendritic cell chemotaxis (GO:0002407) | 2.45554206 |
| 86 | response to type I interferon (GO:0034340) | 2.44936680 |
| 87 | microglial cell activation (GO:0001774) | 2.44902207 |
| 88 | clathrin coat assembly (GO:0048268) | 2.43502537 |
| 89 | response to laminar fluid shear stress (GO:0034616) | 2.42802636 |
| 90 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.41959370 |
| 91 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.41959370 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41221920 |
| 93 | macrophage activation involved in immune response (GO:0002281) | 2.40174325 |
| 94 | cellular extravasation (GO:0045123) | 2.39331040 |
| 95 | positive regulation of isotype switching (GO:0045830) | 2.38777766 |
| 96 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.38654593 |
| 97 | regulation of defense response to virus by virus (GO:0050690) | 2.38165334 |
| 98 | protein localization to endosome (GO:0036010) | 2.37018204 |
| 99 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.35568736 |
| 100 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.35194877 |
| 101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34624598 |
| 102 | positive regulation of interleukin-2 production (GO:0032743) | 2.34281390 |
| 103 | positive regulation of astrocyte differentiation (GO:0048711) | 2.29740544 |
| 104 | T cell proliferation (GO:0042098) | 2.29566292 |
| 105 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.29015911 |
| 106 | leukocyte tethering or rolling (GO:0050901) | 2.28775652 |
| 107 | alpha-beta T cell activation (GO:0046631) | 2.25533331 |
| 108 | regulation of hypersensitivity (GO:0002883) | 2.25310502 |
| 109 | natural killer cell differentiation (GO:0001779) | 2.24955226 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.24568694 |
| 111 | cortical actin cytoskeleton organization (GO:0030866) | 2.22319860 |
| 112 | myeloid dendritic cell activation (GO:0001773) | 2.20246561 |
| 113 | alpha-beta T cell differentiation (GO:0046632) | 2.18481478 |
| 114 | signal complex assembly (GO:0007172) | 2.17851449 |
| 115 | neutrophil activation (GO:0042119) | 2.17095730 |
| 116 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.15512068 |
| 117 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.14002542 |
| 118 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.13315016 |
| 119 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.11472347 |
| 120 | T-helper cell differentiation (GO:0042093) | 2.11472347 |
| 121 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.11127021 |
| 122 | modulation by symbiont of host cellular process (GO:0044068) | 2.09943609 |
| 123 | granulocyte activation (GO:0036230) | 2.08589209 |
| 124 | myeloid cell activation involved in immune response (GO:0002275) | 2.08291371 |
| 125 | regulation of protein heterodimerization activity (GO:0043497) | 2.08145148 |
| 126 | B cell receptor signaling pathway (GO:0050853) | 2.08051139 |
| 127 | cellular defense response (GO:0006968) | 2.06078919 |
| 128 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.05917375 |
| 129 | B cell homeostasis (GO:0001782) | 2.05063157 |
| 130 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.04039794 |
| 131 | T cell mediated immunity (GO:0002456) | 2.03642852 |
| 132 | natural killer cell activation (GO:0030101) | 2.03577838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.75774076 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.69543296 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.88305617 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.38868373 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.25695981 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.14528214 |
| 7 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.56026812 |
| 8 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.53884390 |
| 9 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.39098377 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.34939835 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.29583318 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.27337355 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27287627 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.26758114 |
| 15 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.24241808 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.19968395 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13943121 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.10961854 |
| 19 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.09944820 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06936688 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.97578770 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 1.93823812 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92874345 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 1.92412422 |
| 25 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90457224 |
| 26 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.82576789 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.79797935 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.76688980 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74713935 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63916257 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63592604 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61086960 |
| 33 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.60007334 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55564514 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.54247178 |
| 36 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.53505505 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.52987762 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51354155 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48966819 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47208351 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46044015 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45701772 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45289034 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44407648 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.43548814 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42443639 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40610975 |
| 48 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.40222240 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.39909587 |
| 50 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39391460 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36317348 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.35913103 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35285976 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34251943 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33322169 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31003553 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30074265 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29589256 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28904532 |
| 60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28295043 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27025796 |
| 62 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24094523 |
| 63 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21786275 |
| 64 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20312428 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19126188 |
| 66 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18218637 |
| 67 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.17827682 |
| 68 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15895114 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13023513 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11075230 |
| 71 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.10982841 |
| 72 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.10052228 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.08998603 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07759088 |
| 75 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05677299 |
| 76 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05677299 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03754908 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03380474 |
| 79 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.02629686 |
| 80 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02447677 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02073043 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01421081 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01223439 |
| 84 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.00416325 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99222106 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98657543 |
| 87 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98527584 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98472380 |
| 89 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.97944140 |
| 90 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96931912 |
| 91 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95248073 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94151730 |
| 93 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.93449408 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93153555 |
| 95 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92800843 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92680698 |
| 97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92519041 |
| 98 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.91870605 |
| 99 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.91126426 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90461652 |
| 101 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90304327 |
| 102 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90304327 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89944606 |
| 104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88918842 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88628620 |
| 106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87935299 |
| 107 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.87738368 |
| 108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86818148 |
| 109 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.86804309 |
| 110 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.86622360 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86489451 |
| 112 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86140242 |
| 113 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.85622131 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84332082 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83101798 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81956537 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81372662 |
| 118 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.80053011 |
| 119 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79381129 |
| 120 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.77869291 |
| 121 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.77869291 |
| 122 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.77869291 |
| 123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77119980 |
| 124 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.75589307 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73118276 |
| 126 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.65734173 |
| 127 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.64761545 |
| 128 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.63145843 |
| 129 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.62696223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.36294323 |
| 2 | MP0003724_increased_susceptibility_to | 2.96817911 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.91259972 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.73576275 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.67539840 |
| 6 | MP0005671_abnormal_response_to | 2.54741525 |
| 7 | MP0006082_CNS_inflammation | 2.38683167 |
| 8 | MP0004510_myositis | 2.31984438 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.31661102 |
| 10 | MP0000685_abnormal_immune_system | 2.26303246 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.25306358 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.23580378 |
| 13 | MP0003436_decreased_susceptibility_to | 2.21811976 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.09188217 |
| 15 | MP0002006_tumorigenesis | 2.05068633 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.02177084 |
| 17 | MP0001790_abnormal_immune_system | 2.00234679 |
| 18 | MP0005387_immune_system_phenotype | 2.00234679 |
| 19 | MP0004947_skin_inflammation | 1.99689538 |
| 20 | MP0001819_abnormal_immune_cell | 1.93276787 |
| 21 | MP0002420_abnormal_adaptive_immunity | 1.91721447 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.91714070 |
| 23 | MP0001800_abnormal_humoral_immune | 1.90672961 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.89997411 |
| 25 | MP0003448_altered_tumor_morphology | 1.88648640 |
| 26 | MP0002723_abnormal_immune_serum | 1.83305618 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.81332382 |
| 28 | MP0000858_altered_metastatic_potential | 1.74022048 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.71833701 |
| 30 | MP0003091_abnormal_cell_migration | 1.69131290 |
| 31 | MP0000703_abnormal_thymus_morphology | 1.66646965 |
| 32 | MP0004381_abnormal_hair_follicle | 1.64236473 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.61566878 |
| 34 | MP0002405_respiratory_system_inflammati | 1.61155148 |
| 35 | MP0002398_abnormal_bone_marrow | 1.59794085 |
| 36 | MP0002419_abnormal_innate_immunity | 1.59390621 |
| 37 | MP0002254_reproductive_system_inflammat | 1.59171755 |
| 38 | MP0005025_abnormal_response_to | 1.57371767 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.55308894 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.49585855 |
| 41 | MP0000716_abnormal_immune_system | 1.48764467 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.47582679 |
| 43 | MP0004859_abnormal_synaptic_plasticity | 1.46934279 |
| 44 | MP0003690_abnormal_glial_cell | 1.41096244 |
| 45 | MP0003045_fibrosis | 1.37122270 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.35362776 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.35296937 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.34989901 |
| 49 | MP0005623_abnormal_meninges_morphology | 1.34477769 |
| 50 | MP0001851_eye_inflammation | 1.34260995 |
| 51 | MP0005310_abnormal_salivary_gland | 1.30193824 |
| 52 | MP0008260_abnormal_autophagy | 1.29739951 |
| 53 | MP0002722_abnormal_immune_system | 1.29543539 |
| 54 | MP0003866_abnormal_defecation | 1.28630623 |
| 55 | MP0009278_abnormal_bone_marrow | 1.25827277 |
| 56 | MP0009785_altered_susceptibility_to | 1.25354280 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.24631000 |
| 58 | MP0003329_amyloid_beta_deposits | 1.24546654 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.23258210 |
| 60 | MP0002933_joint_inflammation | 1.21603034 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.20565988 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.19520239 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.18851752 |
| 64 | MP0002009_preneoplasia | 1.14580200 |
| 65 | MP0000733_abnormal_muscle_development | 1.12967436 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.11223278 |
| 67 | MP0005023_abnormal_wound_healing | 1.10811455 |
| 68 | MP0004858_abnormal_nervous_system | 1.06974543 |
| 69 | MP0002429_abnormal_blood_cell | 1.06950353 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.03330252 |
| 71 | MP0008469_abnormal_protein_level | 1.01188940 |
| 72 | MP0003787_abnormal_imprinting | 0.97996446 |
| 73 | MP0001873_stomach_inflammation | 0.97193194 |
| 74 | MP0000604_amyloidosis | 0.91618756 |
| 75 | MP0004130_abnormal_muscle_cell | 0.91463632 |
| 76 | MP0009764_decreased_sensitivity_to | 0.90469797 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.89462053 |
| 78 | MP0001663_abnormal_digestive_system | 0.88826852 |
| 79 | MP0005174_abnormal_tail_pigmentation | 0.87976312 |
| 80 | MP0005166_decreased_susceptibility_to | 0.86642245 |
| 81 | MP0001853_heart_inflammation | 0.84642676 |
| 82 | MP0002396_abnormal_hematopoietic_system | 0.83734736 |
| 83 | MP0004142_abnormal_muscle_tone | 0.82969046 |
| 84 | MP0000920_abnormal_myelination | 0.82673168 |
| 85 | MP0000537_abnormal_urethra_morphology | 0.79888733 |
| 86 | MP0010307_abnormal_tumor_latency | 0.79433383 |
| 87 | MP0003279_aneurysm | 0.78923378 |
| 88 | MP0005257_abnormal_intraocular_pressure | 0.78257112 |
| 89 | MP0003635_abnormal_synaptic_transmissio | 0.77182072 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 0.75332291 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.75109292 |
| 92 | MP0009053_abnormal_anal_canal | 0.74781123 |
| 93 | MP0009379_abnormal_foot_pigmentation | 0.74599267 |
| 94 | MP0005164_abnormal_response_to | 0.74467115 |
| 95 | MP0000627_abnormal_mammary_gland | 0.74273156 |
| 96 | MP0001542_abnormal_bone_strength | 0.73502595 |
| 97 | MP0001299_abnormal_eye_distance/ | 0.72218201 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.72190788 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.71783897 |
| 100 | MP0005275_abnormal_skin_tensile | 0.70986405 |
| 101 | MP0000778_abnormal_nervous_system | 0.70950329 |
| 102 | MP0001849_ear_inflammation | 0.69865242 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.68796840 |
| 104 | MP0003828_pulmonary_edema | 0.66599294 |
| 105 | MP0005390_skeleton_phenotype | 0.66566247 |
| 106 | MP0008569_lethality_at_weaning | 0.66482197 |
| 107 | MP0002163_abnormal_gland_morphology | 0.64035739 |
| 108 | MP0000490_abnormal_crypts_of | 0.62979212 |
| 109 | MP0003075_altered_response_to | 0.61428195 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.61411511 |
| 111 | MP0002064_seizures | 0.61359201 |
| 112 | MP0001958_emphysema | 0.61146319 |
| 113 | MP0005388_respiratory_system_phenotype | 0.61080041 |
| 114 | MP0002133_abnormal_respiratory_system | 0.61080041 |
| 115 | MP0004883_abnormal_blood_vessel | 0.60863694 |
| 116 | MP0004811_abnormal_neuron_physiology | 0.60334499 |
| 117 | MP0002063_abnormal_learning/memory/cond | 0.59950254 |
| 118 | MP0003634_abnormal_glial_cell | 0.59907192 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.59228994 |
| 120 | MP0003795_abnormal_bone_structure | 0.59045936 |
| 121 | MP0005397_hematopoietic_system_phenotyp | 0.58357878 |
| 122 | MP0001545_abnormal_hematopoietic_system | 0.58357878 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.54950027 |
| 124 | MP0000249_abnormal_blood_vessel | 0.53960123 |
| 125 | MP0001440_abnormal_grooming_behavior | 0.53864120 |
| 126 | MP0000343_altered_response_to | 0.52782986 |
| 127 | MP0009763_increased_sensitivity_to | 0.51913065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 3.37943989 |
| 2 | Abnormality of T cell number (HP:0011839) | 3.34935665 |
| 3 | Increased IgM level (HP:0003496) | 3.30670611 |
| 4 | Cerebral aneurysm (HP:0004944) | 3.23875259 |
| 5 | Arterial tortuosity (HP:0005116) | 3.23157311 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.14454456 |
| 7 | Neurofibrillary tangles (HP:0002185) | 3.07540948 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 2.98389559 |
| 9 | Stomatitis (HP:0010280) | 2.94533096 |
| 10 | Eczematoid dermatitis (HP:0000976) | 2.92388257 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 2.87381621 |
| 12 | Disinhibition (HP:0000734) | 2.86752369 |
| 13 | Vascular tortuosity (HP:0004948) | 2.83383106 |
| 14 | Meningitis (HP:0001287) | 2.82527106 |
| 15 | Spontaneous hematomas (HP:0007420) | 2.80901357 |
| 16 | Granulocytopenia (HP:0001913) | 2.78849545 |
| 17 | Mutism (HP:0002300) | 2.73989330 |
| 18 | Encephalitis (HP:0002383) | 2.72325899 |
| 19 | Vasculitis (HP:0002633) | 2.68180761 |
| 20 | Recurrent abscess formation (HP:0002722) | 2.63474545 |
| 21 | Increased density of long bones (HP:0006392) | 2.60053648 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57729263 |
| 23 | Pulmonary infiltrates (HP:0002113) | 2.54663216 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.54095312 |
| 25 | Myositis (HP:0100614) | 2.53562266 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 2.52327637 |
| 27 | Subacute progressive viral hepatitis (HP:0006572) | 2.49081010 |
| 28 | IgG deficiency (HP:0004315) | 2.46005964 |
| 29 | Aortic aneurysm (HP:0004942) | 2.45722530 |
| 30 | Pustule (HP:0200039) | 2.44736339 |
| 31 | Shallow orbits (HP:0000586) | 2.42315706 |
| 32 | Thin bony cortex (HP:0002753) | 2.41238155 |
| 33 | Recurrent viral infections (HP:0004429) | 2.40066915 |
| 34 | Abnormality of oral frenula (HP:0000190) | 2.37983489 |
| 35 | Hypergammaglobulinemia (HP:0010702) | 2.32957708 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.32359338 |
| 37 | Recurrent skin infections (HP:0001581) | 2.29336106 |
| 38 | Diplopia (HP:0000651) | 2.29292476 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.29292476 |
| 40 | Nasal polyposis (HP:0100582) | 2.28667325 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27812247 |
| 42 | Inappropriate behavior (HP:0000719) | 2.25786614 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24551962 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24551962 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24551962 |
| 46 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.24119651 |
| 47 | Frequent falls (HP:0002359) | 2.23556669 |
| 48 | Dilatation of the ascending aorta (HP:0005111) | 2.21366852 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.21353533 |
| 50 | Obstructive sleep apnea (HP:0002870) | 2.20654995 |
| 51 | Hematochezia (HP:0002573) | 2.18342491 |
| 52 | Lymphopenia (HP:0001888) | 2.16031135 |
| 53 | Absent frontal sinuses (HP:0002688) | 2.15063690 |
| 54 | Mitral valve prolapse (HP:0001634) | 2.13925365 |
| 55 | Supernumerary ribs (HP:0005815) | 2.12781548 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.11765893 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.09739583 |
| 58 | Recurrent bronchitis (HP:0002837) | 2.08689171 |
| 59 | Chest pain (HP:0100749) | 2.06578565 |
| 60 | Supranuclear gaze palsy (HP:0000605) | 2.05252300 |
| 61 | Eosinophilia (HP:0001880) | 2.05108368 |
| 62 | Apathy (HP:0000741) | 2.04904046 |
| 63 | Thyroiditis (HP:0100646) | 2.03954436 |
| 64 | Persistence of primary teeth (HP:0006335) | 2.02691830 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.00596083 |
| 66 | Optic neuritis (HP:0100653) | 2.00596083 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 1.99813706 |
| 68 | Striae distensae (HP:0001065) | 1.98429842 |
| 69 | Recurrent bacterial skin infections (HP:0005406) | 1.98144903 |
| 70 | Aortic dissection (HP:0002647) | 1.97701712 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 1.96951069 |
| 72 | IgM deficiency (HP:0002850) | 1.96932876 |
| 73 | Leukocytosis (HP:0001974) | 1.96534883 |
| 74 | Chronic otitis media (HP:0000389) | 1.95963113 |
| 75 | Orchitis (HP:0100796) | 1.95956572 |
| 76 | Bicuspid aortic valve (HP:0001647) | 1.95850682 |
| 77 | Hemoptysis (HP:0002105) | 1.95301980 |
| 78 | Abnormality of eosinophils (HP:0001879) | 1.94136365 |
| 79 | Diminished motivation (HP:0000745) | 1.93595600 |
| 80 | Keratoconjunctivitis (HP:0001096) | 1.92754696 |
| 81 | Hypochromic anemia (HP:0001931) | 1.91377048 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88597258 |
| 83 | Obstructive lung disease (HP:0006536) | 1.88597258 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 1.87837526 |
| 85 | Increased IgE level (HP:0003212) | 1.86958769 |
| 86 | Genu recurvatum (HP:0002816) | 1.86957224 |
| 87 | Thick nail (HP:0001805) | 1.85746117 |
| 88 | Abnormality of T cells (HP:0002843) | 1.84018291 |
| 89 | Hemiplegia (HP:0002301) | 1.83985056 |
| 90 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.82603076 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 1.80067581 |
| 92 | Cellulitis (HP:0100658) | 1.79443199 |
| 93 | Urticaria (HP:0001025) | 1.78642939 |
| 94 | Sepsis (HP:0100806) | 1.78527530 |
| 95 | Disproportionate tall stature (HP:0001519) | 1.78135145 |
| 96 | Oligodontia (HP:0000677) | 1.77776181 |
| 97 | Hypoplasia of the thymus (HP:0000778) | 1.77504785 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 1.77249068 |
| 99 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.76719830 |
| 100 | Hyperacusis (HP:0010780) | 1.76325995 |
| 101 | Atrophic scars (HP:0001075) | 1.74345682 |
| 102 | Increased CSF protein (HP:0002922) | 1.73938379 |
| 103 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.73904573 |
| 104 | Macroorchidism (HP:0000053) | 1.73699030 |
| 105 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.73235505 |
| 106 | Dysostosis multiplex (HP:0000943) | 1.71778040 |
| 107 | Loss of speech (HP:0002371) | 1.70822933 |
| 108 | Narrow palate (HP:0000189) | 1.70369440 |
| 109 | Abnormality of the fingertips (HP:0001211) | 1.69928504 |
| 110 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.69687632 |
| 111 | Slow saccadic eye movements (HP:0000514) | 1.69486735 |
| 112 | Lower limb amyotrophy (HP:0007210) | 1.68618550 |
| 113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.68392501 |
| 114 | Osteolytic defects of the hand bones (HP:0009699) | 1.68392501 |
| 115 | Recurrent cutaneous fungal infections (HP:0011370) | 1.68117179 |
| 116 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.68117179 |
| 117 | Arterial thrombosis (HP:0004420) | 1.68081443 |
| 118 | Alveolar cell carcinoma (HP:0006519) | 1.67697158 |
| 119 | Peritonitis (HP:0002586) | 1.67369719 |
| 120 | Abnormality of the nasal septum (HP:0000419) | 1.66776332 |
| 121 | Periodontitis (HP:0000704) | 1.66734342 |
| 122 | Dislocated radial head (HP:0003083) | 1.66721523 |
| 123 | Pulmonary embolism (HP:0002204) | 1.65283269 |
| 124 | Verrucae (HP:0200043) | 1.64688612 |
| 125 | Papilloma (HP:0012740) | 1.64688612 |
| 126 | Pointed chin (HP:0000307) | 1.63378346 |
| 127 | Myocardial infarction (HP:0001658) | 1.63262598 |
| 128 | Panhypogammaglobulinemia (HP:0003139) | 1.61021808 |
| 129 | Milia (HP:0001056) | 1.60498438 |
| 130 | Abnormality of macrophages (HP:0004311) | 1.60420030 |
| 131 | Ankyloglossia (HP:0010296) | 1.59844420 |
| 132 | Spondylolisthesis (HP:0003302) | 1.58810391 |
| 133 | Abnormality of the radial head (HP:0003995) | 1.58533128 |
| 134 | Viral hepatitis (HP:0006562) | 1.58363880 |
| 135 | Papilledema (HP:0001085) | 1.58011794 |
| 136 | Aqueductal stenosis (HP:0002410) | 1.57668700 |
| 137 | Achilles tendon contracture (HP:0001771) | 1.57622755 |
| 138 | Gingivitis (HP:0000230) | 1.56148010 |
| 139 | Combined immunodeficiency (HP:0005387) | 1.56047406 |
| 140 | Exotropia (HP:0000577) | 1.55976214 |
| 141 | Arnold-Chiari malformation (HP:0002308) | 1.55963401 |
| 142 | Inflammation of the large intestine (HP:0002037) | 1.55667357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 2.71145024 |
| 2 | MAP3K10 | 2.70119882 |
| 3 | MAP4K1 | 2.62193298 |
| 4 | ITK | 2.49414983 |
| 5 | PRPF4B | 2.49342812 |
| 6 | MAP3K9 | 2.46252097 |
| 7 | TGFBR2 | 2.39293541 |
| 8 | SIK2 | 2.08518686 |
| 9 | STK10 | 2.07997685 |
| 10 | PKN2 | 2.04012527 |
| 11 | SIK3 | 1.93670582 |
| 12 | MAP3K13 | 1.91055954 |
| 13 | TYK2 | 1.87736904 |
| 14 | TRIB3 | 1.86916230 |
| 15 | FGFR3 | 1.86101233 |
| 16 | TTN | 1.83279251 |
| 17 | JAK1 | 1.82614184 |
| 18 | EEF2K | 1.82196249 |
| 19 | FGFR4 | 1.77200772 |
| 20 | JAK3 | 1.73115237 |
| 21 | MARK1 | 1.69754652 |
| 22 | GRK6 | 1.69399675 |
| 23 | SCYL2 | 1.65271716 |
| 24 | MAP3K14 | 1.58932070 |
| 25 | RIPK1 | 1.58691002 |
| 26 | ZAP70 | 1.55018211 |
| 27 | TBK1 | 1.42673366 |
| 28 | PTK6 | 1.42139284 |
| 29 | IRAK4 | 1.39415184 |
| 30 | TAOK3 | 1.35312648 |
| 31 | HCK | 1.34641883 |
| 32 | ALK | 1.31504087 |
| 33 | NTRK2 | 1.31251120 |
| 34 | LRRK2 | 1.30054254 |
| 35 | TYRO3 | 1.28275386 |
| 36 | EPHB1 | 1.26802684 |
| 37 | CSK | 1.23708565 |
| 38 | IKBKE | 1.21453758 |
| 39 | LCK | 1.19398617 |
| 40 | DMPK | 1.16193261 |
| 41 | PDGFRB | 1.10638122 |
| 42 | PRKCH | 1.04056349 |
| 43 | BLK | 1.03687538 |
| 44 | LYN | 1.00488607 |
| 45 | CAMK1G | 0.99141018 |
| 46 | FGFR2 | 0.98881824 |
| 47 | CDK6 | 0.98063508 |
| 48 | RET | 0.96614828 |
| 49 | KSR1 | 0.95118058 |
| 50 | SIK1 | 0.94481486 |
| 51 | PASK | 0.94388030 |
| 52 | IKBKB | 0.93853408 |
| 53 | MAP3K3 | 0.91649105 |
| 54 | CDK12 | 0.91510214 |
| 55 | PAK4 | 0.90285845 |
| 56 | PTK2 | 0.90166253 |
| 57 | CSF1R | 0.89080039 |
| 58 | CHUK | 0.87426154 |
| 59 | TNIK | 0.87038452 |
| 60 | UHMK1 | 0.85546498 |
| 61 | TNK2 | 0.84964603 |
| 62 | FES | 0.84913996 |
| 63 | MAP3K2 | 0.83490002 |
| 64 | MOS | 0.83262749 |
| 65 | BMX | 0.82851728 |
| 66 | RPS6KA4 | 0.82677748 |
| 67 | PDGFRA | 0.82548241 |
| 68 | MAPK7 | 0.81558078 |
| 69 | STK24 | 0.81070609 |
| 70 | CAMKK1 | 0.79249756 |
| 71 | NTRK1 | 0.78875440 |
| 72 | EPHA3 | 0.76932238 |
| 73 | JAK2 | 0.76260823 |
| 74 | MARK3 | 0.74335529 |
| 75 | MAP3K11 | 0.74156366 |
| 76 | RIPK4 | 0.74013025 |
| 77 | SYK | 0.73837264 |
| 78 | MAP2K3 | 0.72655737 |
| 79 | TAOK1 | 0.72346215 |
| 80 | STK11 | 0.71564710 |
| 81 | PAK6 | 0.71040487 |
| 82 | MST4 | 0.70994250 |
| 83 | BMPR2 | 0.70871373 |
| 84 | CAMKK2 | 0.66878273 |
| 85 | CDC42BPA | 0.64962017 |
| 86 | FYN | 0.64492297 |
| 87 | TEC | 0.62437843 |
| 88 | PIK3CA | 0.62435341 |
| 89 | CDK19 | 0.62431782 |
| 90 | MAP3K1 | 0.61886789 |
| 91 | FGFR1 | 0.61785761 |
| 92 | SGK2 | 0.61034546 |
| 93 | HIPK2 | 0.60583512 |
| 94 | SGK494 | 0.58578465 |
| 95 | SGK223 | 0.58578465 |
| 96 | FGR | 0.58280178 |
| 97 | CAMK1D | 0.57713949 |
| 98 | GRK7 | 0.56209159 |
| 99 | DYRK1B | 0.56079183 |
| 100 | INSR | 0.55482043 |
| 101 | KIT | 0.54832650 |
| 102 | EGFR | 0.53980851 |
| 103 | PRKCQ | 0.51637754 |
| 104 | RPS6KA2 | 0.50399628 |
| 105 | MAPK12 | 0.49593856 |
| 106 | BTK | 0.49316034 |
| 107 | EPHB2 | 0.48888234 |
| 108 | YES1 | 0.48807522 |
| 109 | KSR2 | 0.47666080 |
| 110 | PAK3 | 0.47378075 |
| 111 | MAP3K7 | 0.47119707 |
| 112 | CDK4 | 0.47010558 |
| 113 | SRC | 0.46174747 |
| 114 | CASK | 0.45253541 |
| 115 | MELK | 0.45186876 |
| 116 | NTRK3 | 0.44134082 |
| 117 | PDK1 | 0.43669836 |
| 118 | IRAK1 | 0.43295809 |
| 119 | CDK5 | 0.42725330 |
| 120 | SGK3 | 0.41538718 |
| 121 | GSK3A | 0.41497532 |
| 122 | BRD4 | 0.40437442 |
| 123 | ILK | 0.40286742 |
| 124 | PAK2 | 0.40036673 |
| 125 | ROCK2 | 0.39997187 |
| 126 | PIM1 | 0.39691944 |
| 127 | MARK2 | 0.38853291 |
| 128 | MINK1 | 0.38698117 |
| 129 | STK38 | 0.37045796 |
| 130 | EPHA2 | 0.36332956 |
| 131 | NLK | 0.35785867 |
| 132 | TRPM7 | 0.34813093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94555022 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82630434 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.70991205 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60545311 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56255767 |
| 6 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46655993 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46597541 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.41714484 |
| 9 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.41201241 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40476235 |
| 11 | Colorectal cancer_Homo sapiens_hsa05210 | 1.39515908 |
| 12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39344909 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36787088 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36209292 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.36051546 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34176049 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32370233 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30848441 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28485420 |
| 20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24662237 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23645912 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22628467 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19820740 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18243512 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17969940 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.17076486 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13633186 |
| 28 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13416222 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11543555 |
| 30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09372372 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.08874149 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08842178 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07414412 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07357612 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05707280 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04877220 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.03658461 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03381558 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02812921 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.01658560 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 1.01599700 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.00492022 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00021842 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99506108 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98909918 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.98459889 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 0.97404638 |
| 48 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95893489 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.94393149 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 0.94010963 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 0.93485664 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91686706 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90388659 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90045767 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89780251 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 0.89519724 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89259175 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89147857 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88479038 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.88431203 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88389842 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.88377113 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85974011 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85493514 |
| 65 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84671064 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84625304 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83161382 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82079425 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.81690256 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80827861 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80197279 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79346355 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78996778 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78949884 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.78322298 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.77816406 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77488244 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77378588 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76750100 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76498602 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.75596193 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75085994 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75000590 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74545951 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74391060 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74270947 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.73601127 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73308974 |
| 89 | Legionellosis_Homo sapiens_hsa05134 | 0.72944777 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72268704 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72009918 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.71030171 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71007409 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71002786 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70951697 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70917927 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70749576 |
| 98 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70616399 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70256575 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.69449896 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67219355 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67135720 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66853092 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66286128 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66234351 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66135781 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.64434230 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64210818 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.63748577 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63689506 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61994441 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.56379136 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54907433 |
| 114 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54479979 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53085942 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51242632 |
| 117 | Morphine addiction_Homo sapiens_hsa05032 | 0.49341735 |

